Citadel Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $929K | Buy |
9,600
+2,600
| +37% | +$267K | ﹤0.01% | 7823 |
|
|
2025
Q4 | $743K | Sell |
7,000
-900
| -11% | -$104K | ﹤0.01% | 8075 |
|
|
2025
Q3 | $1M | Buy |
7,900
+4,700
| +147% | +$560K | ﹤0.01% | 7534 |
|
|
2025
Q2 | $392K | Sell |
3,200
-108,200
| -97% | -$12.4M | ﹤0.01% | 9187 |
|
|
2025
Q1 | $11.3M | Buy |
111,400
+106,900
| +2,376% | +$10.4M | ﹤0.01% | 2697 |
|
|
2024
Q4 | $416K | Sell |
4,500
-400
| -8% | -$39.3K | ﹤0.01% | 8968 |
|
|
2024
Q3 | $474K | Sell |
4,900
-3,400
| -41% | -$306K | ﹤0.01% | 8376 |
|
|
2024
Q2 | $712K | Sell |
8,300
-14,000
| -63% | -$1.17M | ﹤0.01% | 7329 |
|
|
2024
Q1 | $1.84M | Buy |
22,300
+21,700
| +3,617% | +$1.59M | ﹤0.01% | 5686 |
|
|
2023
Q4 | $40K | Sell |
600
-8,000
| -93% | -$518K | ﹤0.01% | 12018 |
|
|
2023
Q3 | $578K | Hold |
8,600
| – | – | ﹤0.01% | 7740 |
|
|
2023
Q2 | $582K | Sell |
8,600
-4,800
| -36% | -$301K | ﹤0.01% | 7609 |
|
|
2023
Q1 | $725K | Buy |
13,400
+8,400
| +168% | +$489K | ﹤0.01% | 7481 |
|
|
2022
Q4 | $299K | Sell |
5,000
-19,000
| -79% | -$1.03M | ﹤0.01% | 9329 |
|
|
2022
Q3 | $1.09M | Buy |
24,000
+10,550
| +78% | +$528K | ﹤0.01% | 6823 |
|
|
2022
Q2 | $600K | Sell |
13,450
-13,827
| -51% | -$709K | ﹤0.01% | 8222 |
|
|
2022
Q1 | $1.54M | Sell |
27,277
-47,640
| -64% | -$2.49M | ﹤0.01% | 6663 |
|
|
2021
Q4 | $3.89M | Sell |
74,917
-8,925
| -11% | -$460K | ﹤0.01% | 4809 |
|
|
2021
Q3 | $5M | Sell |
83,842
-4,651
| -5% | -$293K | ﹤0.01% | 4293 |
|
|
2021
Q2 | $5.49M | Buy |
88,493
+68,381
| +340% | +$4.56M | ﹤0.01% | 4232 |
|
|
2021
Q1 | $1.31M | Buy |
+20,112
| New | +$1.31M | ﹤0.01% | 7444 |
|
|
2020
Q4 | – | Sell |
-8,799
| Closed | -$455K | – | 11044 |
|
|
2020
Q3 | $455K | Sell |
8,799
-30,545
| -78% | -$1.57M | ﹤0.01% | 7467 |
|
|
2020
Q2 | $1.94M | Sell |
39,344
-1,886
| -5% | -$102K | ﹤0.01% | 4636 |
|
|
2020
Q1 | $2.1M | Buy |
41,230
+31,174
| +310% | +$1.8M | ﹤0.01% | 4066 |
|
|
2019
Q4 | $554K | Sell |
10,056
-3,017
| -23% | -$164K | ﹤0.01% | 6651 |
|
|
2019
Q3 | $658K | Sell |
13,073
-28,282
| -68% | -$1.42M | ﹤0.01% | 6277 |
|
|
2019
Q2 | $2.08M | Buy |
41,355
+125
| +0.3% | +$6.07K | ﹤0.01% | 4446 |
|
|
2019
Q1 | $1.92M | Buy |
41,230
+18,478
| +81% | +$936K | ﹤0.01% | 4539 |
|
|
2018
Q4 | $1.12M | Buy |
22,752
+4,651
| +26% | +$265K | ﹤0.01% | 5140 |
|
|
2018
Q3 | $1.12M | Buy |
18,101
+7,919
| +78% | +$482K | ﹤0.01% | 5334 |
|
|
2018
Q2 | $549K | Buy |
10,182
+2,766
| +37% | +$138K | ﹤0.01% | 6214 |
|
|
2018
Q1 | $337K | Buy |
+7,416
| New | +$318K | ﹤0.01% | 6556 |
|
|
2016
Q1 | – | Sell |
-4,777
| Closed | -$132K | – | 7053 |
|
|
2015
Q4 | $132K | Sell |
4,777
-10,684
| -69% | -$304K | ﹤0.01% | 6373 |
|
|
2015
Q3 | $472K | Sell |
15,461
-31,174
| -67% | -$1.09M | ﹤0.01% | 4881 |
|
|
2015
Q2 | $1.71M | Buy |
46,635
+7,291
| +19% | +$260K | ﹤0.01% | 3241 |
|
|
2015
Q1 | $1.39M | Buy |
39,344
+13,827
| +54% | +$473K | ﹤0.01% | 3532 |
|
|
2014
Q4 | $781K | Buy |
25,517
+19,106
| +298% | +$596K | ﹤0.01% | 4088 |
|
|
2014
Q3 | $188K | Buy |
+6,411
| New | +$195K | ﹤0.01% | 5785 |
|
|
2014
Q2 | – | Sell |
-2,388
| Closed | -$68K | – | 8027 |
|
|
2014
Q1 | $68K | Buy |
2,388
+125
| +6% | +$3.25K | ﹤0.01% | 6514 |
|
|
2013
Q4 | $60K | Buy |
+2,263
| New | +$63K | ﹤0.01% | 5936 |
|
|
2013
Q3 | – | Sell |
-1,383
| Closed | -$32K | – | 6763 |
|
|
2013
Q2 | $32K | Buy |
+1,383
| New | +$31.3K | ﹤0.01% | 5867 |
|
Other funds holding EHC
VPM
VCM
Citadel Advisors's EHC Position: Q1 2026 in Review
Citadel Advisors increased its Encompass Health (EHC) stake by 336% in Q1 2026, buying an estimated $40.4M and bringing the position to 511,887 shares worth $49.5M. The position accounts for 0.01% of the portfolio, ranked #1369.
Citadel Advisors first reported a position in EHC in Q2 2013 and has held it in 50 quarters since. The position peaked at $132M in Q2 2024. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Citadel Advisors held 511,887 shares of Encompass Health worth $49.5M as of Q1 2026.
- Citadel Advisors bought 394,416 Encompass Health shares in Q1 2026, an estimated $40.4M.
- Encompass Health made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1369 holding.
- Citadel Advisors first reported a position in Encompass Health in Q2 2013 and has held it in 50 quarters since.
- Citadel Advisors's Encompass Health position peaked at $132M in Q2 2024.
- 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.